¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ 10¿ù ÀÇ°úÇкоߺ° ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 

 

 

[10¿ù ÀÇ°úÇкоߺ° ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå]

 


 

Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ÀÇ°úÇкоßÀÇ ±¹³» ¹× ±¹Á¦ Àú³Î¿¡ 10¿ù¿¡ ¹ßÇ¥µÈ ³í¹®Àº ±¹³» Àú³ÎÀ» ÅëÇØ 1,685Æí, ±¹¿Ü Àú³ÎÀ» ÅëÇÑ ³í¹® 2,003ÆíÀ¸·Î ÃÑ 3,688ÆíÀÌ ¹ßÇ¥µÇ¾ú´Ù. ÀÌ´Â Àü¿ù 9¿ù ¹ßÇ¥µÈ 3,555Æí¿¡ ºñ±³ÇÏ¿© 3.91%(133Æí) °¨¼ÒÇÑ Ãß¼¼¸¦ ³ªÅ¸³»¾ú´Ù. ÀÇ°úÇÐ ºÐ¾ßº°·Î ±¹³»¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ Å°¿öµå¸¦ ±âÃÊÀÇÇÐ, ÀÓ»óÀÇÇÐ, ¿¹¹æÀÇÇÐ, Ä¡ÀÇÇÐ, °£È£ÇÐ, ÅëÇÕÀÇ°úÇÐ ºÐ¾ßÀÇ ÃֽŠÇÙ½É ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå ¹× Å°¿öµå´Â ¾Æ·¡ Ç¥¿Í °°´Ù.  

 




 

 

            ±×¸² 1. ÅëÇÕ ÀÇ°úÇÐ ºÐ¾ß  ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)






 

ÀÇ°úÇÐ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå(n=3,688)

Å°¿öµå ¼øÀ§

±¹³» ÀÇ°úÇÐ ¿¬±¸µ¿Çâ 

±¹¿Ü ÀÇ°úÇÐ ¿¬±¸µ¿Çâ

ÀÇ°úÇÐ ¿¬±¸µ¿Çâ 

1

Women

Genes

Risk

2

General Surgery

Risk

Genes

3

COVID-19

Neoplasms

Women

4

Risk

Humans

Neoplasms

5

Neoplasms

Attention

General Surgery

6

Pain

Women

COVID-19

7

Complication

Role

Humans

8

Genes

General Surgery

Role

9

Survival Rate

Economics

Attention

10

Education

Survival Rate

Survival Rate










 

 

        ±×¸² 2. ÀÓ»óºÐ¾ß ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)


 



 

ÀÓ»óÀÇÇÐºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=1,777)

Å°¿öµå ¼øÀ§

±¹³» ÀÓ»óÀÇÇÐ Å°¿öµå

±¹¿Ü ÀÓ»óÀÇÇÐ Å°¿öµå

ÅëÇÕÀÓ»óÀÇÇÐ Å°¿öµå 

1

General Surgery

Risk

Risk

2

Women

General Surgery

General Surgery

3

Risk

Women

Women

4

Pain

Survival Rate

Survival Rate

5

Complication

Neoplasms

Complication

6

COVID-19

Complication

Neoplasms

7

Survival Rate

F-18 Fdg Pet

COVID-19

8

Neoplasms

Sensitivity & Specificity

Pain

9

Mortality

Mortality

Mortality

10

Stroke

Recurrence

Recurrence





 

 

         ±×¸² 3. ±âÃÊÀÇÇÐ ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)





 

±âÃÊÀÇÇÐ ºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=1,127)

Å°¿öµå ¼øÀ§

±¹³» ±âÃÊÀÇÇÐ ¿¬±¸ 

±¹¿Ü ±âÃÊÀÇÇÐ ¿¬±¸

ÅëÇÕ ±âÃÊÀÇÇР Å°¿öµå

1

Genes

Genes

Genes

2

Role

Humans

Humans

3

Neoplasms

Economics

Role

4

COVID-19

Neoplasms

Economics

5

Humans

Role

Neoplasms

6

Economics

Attention

Attention

7

Education

Risk

Drug

8

Attention

Drug

Risk

9

DNA

Population

DNA

10

Drug

DNA

COVID-19






 

 

          ±×¸² 4. ¿¹¹æÀÇÇÐ ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå( 2021³â 10¿ù)





 

 

¿¹¹æÀÇÇÐ/º¸°ÇÇР ºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=376)

Å°¿öµå¼øÀ§

±¹³» ¿¹¹æÀÇÇÐ ¿¬±¸µ¿Çâ 

±¹¿Ü ¿¹¹æÀÇÇÐ ¿¬±¸µ¿Çâ

ÅëÇÕ ¿¹¹æÀÇÇÐ Å°¿öµå

1

Income

Attention

Risk

2

Women

Soil

Attention

3

COVID-19

Risk

Women

4

Risk

Water

COVID-19

5

Smoking

Environment

Environment

6

Behavior

COVID-19

Soil

7

Depression

Women

Behavior

8

Environment

Humans

Income

9

Health Care Costs

Pediatrics

Water

10

Family

Efficiency

Pediatrics





 

 

                ±×¸² 5. Ä¡ÀÇÇÐ ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)










 

Ä¡ÀÇÇÐ ºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=231)

Å°¿öµå ¼øÀ§

±¹³» Ä¡ÀÇÇÐ ¿¬±¸µ¿Çâ 

±¹¿Ü Ä¡ÀÇÇÐ ¿¬±¸µ¿Çâ

ÅëÇÕ Ä¡ÀÇÇÐ Å°¿öµå 

1

Tooth

Tooth

Tooth

2

Bone And Bones

General Surgery

Bone & Bones

3

Dental Hygienists

Pain

Pain

4

Oral Health

Temporomandibular Joint

Dental Hygienists

5

Education

Bone And Bones

Oral Health

6

Pain

Biofilms

Temporomandibular Joint

7

Women

Complication

General Surgery

8

Temporomandibular Joint

Recurrence

Education

9

Radiograph

Rotation

Women

10

Pediatrics

Survival Rate

Dental Implants





 

 

          ±×¸² 6. °£È£ÇÐ ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå(2021³â 10¿ù)

 

 





 

°£È£ÇÐ ºÐ¾ß ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå (n=177)

Å°¿öµå ¼øÀ§

±¹³» °£È£ÇÐ ¿¬±¸µ¿Çâ 

±¹¿Ü °£È£ÇÐ ¿¬±¸µ¿Çâ

°£È£ÇÐ ¿¬±¸µ¿Çâ 

1

Education

Depression

Education

2

Behavior

Neoplasms

Depression

3

Women

Family

Women

4

Older Adults

COVID-19

Quality Of Life

5

Quality Of Life

Education

Behavior

6

Depression

Quality Of Life

Older Adults

7

Family

Women

Family

8

COVID-19

Cancer Survivors

COVID-19

9

Social Support

Attitude

Attitude

10

Aptitude

Evaluation Studies As Topic

Neoplasms






 

ÀÇ°úÇÐ ºÐ¾ßº° ³í¹® ¹ßÇ¥ÇöȲÀº ÀÓ»óÀÇÇÐ ±¹³» 1,004Æí°ú, ±¹¿Ü¹ßÇ¥ 773ÆíÀ¸·Î ÃÑ 1,778ÆíÀÌ ¹ßÇ¥µÇ¾úÀ¸¸ç ÀÌ´Â ÀÇ°úÇко߿¡¼­ °¡Àå ¸¹Àº ¹ßÇ¥¼øÀ§¸¦ ³ªÅ¸³»¾ú´Ù. ±× µÚ¸¦ ÀÌ¾î ±âÃÊÀÇÇÐ 1,127ÆíÀ¸·Î ÀÌ´Â ±¹³»¹ßÇ¥°¡ 201Æí, ±¹¿Ü¹ßÇ¥ 926ÆíÀ¸·Î ³ªÅ¸³µ´Ù. ¿¹¹æÀÇÇÐ/º¸°ÇÇкоߴ ±¹³» 158Æí, ±¹¿Ü 218Æí, °£È£Çкоߴ ±¹³» 133Æí, ±¹¿ÜÀú³ÎÀ» ÅëÇØ 44ÆíÀÌ ¹ßÇ¥µÇ¾úÀ¸¸ç, Ä¡ÀÇÇÐÀº ±¹³» 189Æí, ±¹¿ÜÀú³ÎÀ» ÅëÇØ 42ÆíÀÌ ¹ßÇ¥µÇ¾ú´Ù. ƯÈ÷ Ä¡ÀÇÇкоßÀÇ ±¹³»¿Ü Àú³ÎÀ» ÅëÇÑ ³í¹®¹ßÇ¥´Â Àü¿ù 9¿ù¿¡ ¹ßÇ¥µÈ 79°Ç¿¡ ºñ±³ÇÏ¿© 92.4%°¡ Áõ°¡µÈ 231ÆíÀÌ 10¿ù¿¡ ¹ßÇ¥µÇ¾ú´Ù. ÀÇ°úÇкоߺ° ³í¹®µ¥ÀÌÅÍ ÃßÃâÀ» À§ÇØ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿Í PubMed DB¿¡ À妽ºµÈ ³í¹®µ¥ÀÌÅ͸¦ ÃßÃ⠺м®ÇÏ¿´´Ù. 







 

      ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø





 

* º» ³»¿ëÀº MedRIC (www.medric.or.kr)ÀÇ ¿¬±¸µ¿Çâ¿¡¼­ ¼­ºñ½ºµÇ´Â ³»¿ëÀÔ´Ï´Ù.

 

 

 

 


2021-11-18 ¿ÀÈÄ 5:08:43, Á¶È¸¼ö : 820